Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5024597421
Research Areas
- Global Trade and Competitiveness
- Nanoparticles: synthesis and applications
- Antibiotic Resistance in Bacteria
- CRISPR and Genetic Engineering
- Poxvirus research and outbreaks
- Vaccine Coverage and Hesitancy
- Pharmaceutical Economics and Policy
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
- Agricultural and Food Sciences
- Private Equity and Venture Capital
- Nanoparticle-Based Drug Delivery
- Bacillus and Francisella bacterial research
- Antibiotics Pharmacokinetics and Efficacy
- Virus-based gene therapy research
- Computational Drug Discovery Methods
- Graphene and Nanomaterials Applications
- Biosimilars and Bioanalytical Methods
Instituto Nacional da Propriedade Industrial
2013-2023
Universidade Federal do Rio de Janeiro
2013-2016
10.1007/s43615-021-00051-y
article
EN
other-oa
Circular Economy and Sustainability
2021-07-15
Mpox disease was reported in 110 countries since May 2022, with 88,026 cases and 148 deaths by 21 June 2023. Although some drugs were already approved for treatment, the available smallpox vaccines can provide 85% cross-prevention, but there are no scientific publications describing patent portfolio vaccines. This paper aims to contribute identification of status vaccine patents now applied Mpox. We retrieved ten vaccines, only a few had one under litigation processes three continents. Also,...
10.4155/ppa-2023-0017
article
EN
Pharmaceutical Patent Analyst
2023-05-01
10.48072/2525-7579.rog.2020.051
article
EN
Technical Papers ... Rio Oil & Gas
2020-12-01
Coming Soon ...